Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control study

Abstract Background Transient donor hydrops (TDH) is defined as donor hydrops developed within days after laser therapy for twin–twin transfusion syndrome (TTTS) followed by resolution later. The purpose of this study was to evaluate the incidence, neonatal outcomes and predisposing factors of post...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao-Lung Chang, An-Shine Chao, Shuenn-Dyh Chang, Wen-Fang Li, Po-Jen Cheng
Formato: Artículo
Lenguaje:English
Publicado: BMC 2019-03-01
Colección:BMC Pregnancy and Childbirth
Materias:
Acceso en línea:http://link.springer.com/article/10.1186/s12884-019-2236-4
_version_ 1828312038906003456
author Yao-Lung Chang
An-Shine Chao
Shuenn-Dyh Chang
Wen-Fang Li
Po-Jen Cheng
author_facet Yao-Lung Chang
An-Shine Chao
Shuenn-Dyh Chang
Wen-Fang Li
Po-Jen Cheng
author_sort Yao-Lung Chang
collection DOAJ
description Abstract Background Transient donor hydrops (TDH) is defined as donor hydrops developed within days after laser therapy for twin–twin transfusion syndrome (TTTS) followed by resolution later. The purpose of this study was to evaluate the incidence, neonatal outcomes and predisposing factors of post laser therapy TDH in severe TTTS. Methods A total of 142 patients with severe TTTS who received laser therapy were included into this study. The pre-operative characteristics and neonatal outcomes were compared between TTTS with and without post laser therapy TDH. All live neonates received cranial ultrasound examination after delivery, mild cerebral injury was defined as exhibiting at least one of the following: intraventricular hemorrhage (IVH) grade I and II, lenticulostriate vasculopathy and subependymal pseudocysts; severe cerebral injury comprised at least one among the following: IVH grade III or grade IV, cystic periventriculoleukomalacia (PVL) grade II or more, porencephalic cysts, and ventricular dilatation. Fetal survival was defined as living more than 30 days after delivery. Results
first_indexed 2024-04-13T16:09:22Z
format Article
id doaj.art-e15d3b1498b849c4b5d54c50523b1612
institution Directory Open Access Journal
issn 1471-2393
language English
last_indexed 2024-04-13T16:09:22Z
publishDate 2019-03-01
publisher BMC
record_format Article
series BMC Pregnancy and Childbirth
spelling doaj.art-e15d3b1498b849c4b5d54c50523b16122022-12-22T02:40:18ZengBMCBMC Pregnancy and Childbirth1471-23932019-03-011911610.1186/s12884-019-2236-4Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control studyYao-Lung Chang0An-Shine Chao1Shuenn-Dyh Chang2Wen-Fang Li3Po-Jen Cheng4Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University College of MedicineDepartment of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University College of MedicineDepartment of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University College of MedicineDepartment of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University College of MedicineDepartment of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Chang Gung University College of MedicineAbstract Background Transient donor hydrops (TDH) is defined as donor hydrops developed within days after laser therapy for twin–twin transfusion syndrome (TTTS) followed by resolution later. The purpose of this study was to evaluate the incidence, neonatal outcomes and predisposing factors of post laser therapy TDH in severe TTTS. Methods A total of 142 patients with severe TTTS who received laser therapy were included into this study. The pre-operative characteristics and neonatal outcomes were compared between TTTS with and without post laser therapy TDH. All live neonates received cranial ultrasound examination after delivery, mild cerebral injury was defined as exhibiting at least one of the following: intraventricular hemorrhage (IVH) grade I and II, lenticulostriate vasculopathy and subependymal pseudocysts; severe cerebral injury comprised at least one among the following: IVH grade III or grade IV, cystic periventriculoleukomalacia (PVL) grade II or more, porencephalic cysts, and ventricular dilatation. Fetal survival was defined as living more than 30 days after delivery. Resultshttp://link.springer.com/article/10.1186/s12884-019-2236-4Twin-twin transfusion syndromeDonor hydropsLaser therapyQuintero stage
spellingShingle Yao-Lung Chang
An-Shine Chao
Shuenn-Dyh Chang
Wen-Fang Li
Po-Jen Cheng
Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control study
BMC Pregnancy and Childbirth
Twin-twin transfusion syndrome
Donor hydrops
Laser therapy
Quintero stage
title Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control study
title_full Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control study
title_fullStr Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control study
title_full_unstemmed Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control study
title_short Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control study
title_sort predisposing factors and neonatal outcomes for twin twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation a case control study
topic Twin-twin transfusion syndrome
Donor hydrops
Laser therapy
Quintero stage
url http://link.springer.com/article/10.1186/s12884-019-2236-4
work_keys_str_mv AT yaolungchang predisposingfactorsandneonataloutcomesfortwintwintransfusionsyndromecasesdevelopingtransientdonorhydropsafterfetoscopiclasercoagulationacasecontrolstudy
AT anshinechao predisposingfactorsandneonataloutcomesfortwintwintransfusionsyndromecasesdevelopingtransientdonorhydropsafterfetoscopiclasercoagulationacasecontrolstudy
AT shuenndyhchang predisposingfactorsandneonataloutcomesfortwintwintransfusionsyndromecasesdevelopingtransientdonorhydropsafterfetoscopiclasercoagulationacasecontrolstudy
AT wenfangli predisposingfactorsandneonataloutcomesfortwintwintransfusionsyndromecasesdevelopingtransientdonorhydropsafterfetoscopiclasercoagulationacasecontrolstudy
AT pojencheng predisposingfactorsandneonataloutcomesfortwintwintransfusionsyndromecasesdevelopingtransientdonorhydropsafterfetoscopiclasercoagulationacasecontrolstudy